Found 38 matching trials
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV PHASE1 Study objectives: To evaluate the immunogenicity and immunity persistence a...
Show More Location
Zhejiang Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Clinical Trial of Safety and Immunogenicity of Recombinant SARS-CoV-2 S-Trimer Vaccine (CHO Cells) as Booster Vaccination in Populations Aged 18 to 59 Years EARLY_PHASE1 Increased immune escape of emerging SARS-CoV-2 variants and waning neutrali...
Show More Location
The Fifth Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) NA Popular title: Clinical study of Omicron BA.4/5-Delta strain recombinant no...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) PHASE1 This is a phase I, randomized, placebo-controlled, double-blind study, to e...
Show More Location
Jiangsu Provincial Center for Diseases Control and Prevention
Treatments Being Tested
Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14 Three doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28 Two doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14 Three doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28 Two doses of placebo at the schedule of day 0, 14 #middle-dose group# Three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group# Two doses of placebo at the schedule of day 0, 14 #High-dose group# Three doses of placebo at the schedule of day 0, 14, 28 #High-dose group# Learn More & Join Trial
Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 PHASE1 The purpose of this double-blind, randomized, controlled study is to assess...
Show More Location
Xiangcheng Center for Disease Control and Prevention
Learn More & Join Trial
The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001 EARLY_PHASE1 The goal of this clinical trial is to assess the immunogenicity and safety ...
Show More Location
Chengdu Xinhua Hospital Affiliated to North Sichuan Medical College
Learn More & Join Trial
To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2 NA An open experimental design was used in this study, and 240 subjects were p...
Show More Location
Hunan Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 PHASE2 The purpose of this double-blind, randomized, controlled study is to assess...
Show More Location
Xiangcheng Center for Disease Control and Prevention
Learn More & Join Trial
Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac PHASE1 Study objectives: To evaluate the immunogenicity and immunity persistence a...
Show More Location
Zhejiang Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older PHASE3 This is an international multicenter clinical trial, which is planned to be...
Show More Location
Bishan District People's Hospital,Chongqing
Learn More & Join Trial